Kochanowska, A.; Rusztyn, P.; Szczerkowska, K.; Surma, S.; Gąsecka, A.; Jaguszewski, M.J.; Szarpak, Ł.; Filipiak, K.J.
Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action. J. Cardiovasc. Dev. Dis. 2023, 10, 268.
https://doi.org/10.3390/jcdd10070268
AMA Style
Kochanowska A, Rusztyn P, Szczerkowska K, Surma S, Gąsecka A, Jaguszewski MJ, Szarpak Ł, Filipiak KJ.
Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action. Journal of Cardiovascular Development and Disease. 2023; 10(7):268.
https://doi.org/10.3390/jcdd10070268
Chicago/Turabian Style
Kochanowska, Anna, Przemysław Rusztyn, Karolina Szczerkowska, Stanisław Surma, Aleksandra Gąsecka, Miłosz J. Jaguszewski, Łukasz Szarpak, and Krzysztof J. Filipiak.
2023. "Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action" Journal of Cardiovascular Development and Disease 10, no. 7: 268.
https://doi.org/10.3390/jcdd10070268
APA Style
Kochanowska, A., Rusztyn, P., Szczerkowska, K., Surma, S., Gąsecka, A., Jaguszewski, M. J., Szarpak, Ł., & Filipiak, K. J.
(2023). Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action. Journal of Cardiovascular Development and Disease, 10(7), 268.
https://doi.org/10.3390/jcdd10070268
